Atlas Trials

Guangzhou Gloria Biosciences Co., Ltd.

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Guangzhou Gloria Biosciences Co., Ltd.

RecordFirmDate
Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma Patients (NCT06514508)Guangzhou Gloria Biosciences Co., Ltd.2025-12-01
Safety, Tolerability, and Efficacy of GLS-012 and GLS-010 in Patients With Advanced Non-Small Cell Lung Cancer (NCT05978401)Guangzhou Gloria Biosciences Co., Ltd.2023-08-10
A Study of GLS-010 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer (NCT05798819)Guangzhou Gloria Biosciences Co., Ltd.2023-05-01
Immuno-Oncology Drugs GLS-012 Alone & in Combination GLS-010 Treating With Advanced Patients Solid Tumors (NCT05909436)Guangzhou Gloria Biosciences Co., Ltd.2022-10-31
GLS-010 Monotherapy Versus Chemotherapy in Patients With Relapsed or Refractory Classical Hodgkin's Lymphoma (R/R cHL) (NCT05518318)Guangzhou Gloria Biosciences Co., Ltd.2022-09-01
Study of GLS-010 Injection in Patients With Recurrent or Metastatic Cervical Cancer (NCT03972722)Guangzhou Gloria Biosciences Co., Ltd.2019-05-15
Study of GLS-010 Injection in the Treatment of Classical Hodgkin's Lymphoma (NCT03655483)Guangzhou Gloria Biosciences Co., Ltd.2018-08-24
Study of Recombinant Human Anti-PD-1 Monoclonal Antibody for Patients With Advanced Solid Tumors (NCT03713905)Guangzhou Gloria Biosciences Co., Ltd.2017-07-01

Track Guangzhou Gloria Biosciences Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.